Lotus EYE Hosp & Inst L
NSE: LOTUSEYE · Hospital · sector
₹113.56NSE close 2026-10-26
Key numbers
Market cap₹236 cr
Price₹113.56
52w high / low₹147 / ₹98
P/E1,419.5xSector median 42.5x
P/B3.9xSector median 4.9x
Book value₹28.9
Dividend yield0.01%Sector median 0.17%
ROE0.2%Sector median 12.1%
ROCE2.1%Sector median 13.8%
OPM8.5%Sector median 20.3%
Debt / equity0.19xSector median 0.24x
EV/EBITDA50.4xSector median 23.6x
Interest cover1.2x
Current ratio1.22x
Sales growth 3y+4.5%Sector median +14.1%
Profit growth 3y-73.0%Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹4 cr vs borrowings ₹11 cr (FY26): borrowings are higher by ₹8 cr.
- Operating profit covered interest 1.2x in the last 12 months.
- 87.15% of the promoters' shares are pledged (35.0% of all shares).
- Promoter holding fell by 0.50 percentage points in a year, to 40.14% (2026-09-30).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Net loss in 3 of the last 8 quarters.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 800% of net profit in the last 12 months.
- Dividend paid in 3 of the last 5 financial years.
- Price ₹113.56 on 2026-10-26: -22.7% from the 52-week high, +16.4% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹139.88 · low ₹57.91
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13 | 12 | 12 | 14 | 13 | 14 | 14 | 17 |
| EBITDA | 1 | 1 | -0 | 1 | 1 | 1 | 0 | 3 |
| OPM % | 8.9% | 6.4% | -1.4% | 10.9% | 5.9% | 4.9% | 3.5% | 17.2% |
| Other income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net profit | 0 | -0 | 0 | 1 | 0 | -0 | -0 | 1 |
| EPS (₹) | 0.05 | -0.11 | 0.12 | 0.26 | 0.06 | -0.13 | -0.15 | 0.30 |
| Revenue YoY | +1.0% | +10.6% | +18.2% | +26.2% | ||||
| Profit YoY | +20.0% | – | -228.0% | +13.0% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 39 | 47 | 48 | 50 | 54 | 57 |
| EBITDA | 6 | 8 | 7 | 3 | 3 | 5 |
| Net profit | 3 | 4 | 3 | 1 | 0 | 0 |
| EPS (₹) | 0.00 | 1.96 | 1.40 | 0.36 | 0.04 | 0.08 |
| Revenue growth | +20.9% | +2.5% | +2.8% | +8.4% | +14.1% | |
| Profit growth | +36.9% | -28.7% | -74.6% | -89.2% | -77.4% | |
| Dividend / share (₹) | 0.50 | 0.50 | 0.50 | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +4.5% | +10.7% | +14.1% |
| Net profit | -73.0% | -44.8% | -77.4% |
| EPS | -72.7% | -39.9% | – |
| Share price | – | +26.6% (2y) | -5.8% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 58 | 59 | 60 | 60 |
| Borrowings | – | 0 | 0 | 0 | 11 |
| Cash & equivalents | – | 8 | 7 | 4 | 4 |
| Total assets | – | 63 | 67 | 70 | 83 |
| Fixed assets | – | 44 | 46 | 49 | 59 |
| Capital work in progress | – | 0 | 0 | 0 | 0 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 1 | 1 | 1 | 1 |
| Inventory | – | 3 | 3 | 4 | 4 |
| Payables | – | 3 | 3 | 3 | 3 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 4 | 4 | 6 | 5 | 3 |
| Cash from investing | -4 | -2 | -5 | -4 | -12 |
| Cash from financing | -2 | -2 | -3 | -2 | 9 |
| Capex | 5 | 3 | 6 | 5 | 13 |
| Free cash flow | -0 | 1 | 0 | 0 | -10 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 7.1% | 4.9% | 1.2% | 0.1% |
| ROCE % | – | 10.0% | 6.9% | 2.9% | 1.1% |
| Debtor days | – | 9 | 10 | 10 | 8 |
| Inventory days | – | 68 | 77 | 90 | 84 |
| Payable days | – | 77 | 82 | 79 | 71 |
| Cash conversion cycle (days) | – | 0 | 5 | 21 | 21 |
| Working capital days | – | 74 | 59 | 31 | 14 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 40.14% |
| DIIs | 0.02% |
| Public (non-institutions) | 59.85% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 40.14% | 40.22% | 40.39% | 40.64% | 39.67% | 40.14% | 40.14% | 40.14% |
| Promoter group | % |
|---|---|
| Sangeetha S | 34.98% |
| Kavetha Sundaramoorthy | 2.75% |
| Late Kaliannagounder Sundaramoorthy | 2.41% |
| Sundaramoorthy Rajkumar | 0.00% |
| Asean Optics Private Limited | 0.00% |
| Eyeda Meds LLP | 0.00% |
| Dr S K S Memorial Eye Hospitals Private Limited | 0.00% |
| Public holders above 1% | % |
|---|---|
| Kovai Purani Finance Private Limited | 8.48% |
| Vramath Investment Consultancy Private Limited | 4.84% |
| Vramath Financial Services Private Limited | 4.67% |
| Rajiv Choudhary | 4.53% |
| Sangeeta Choudhary | 3.92% |
| Thomas Santosh | 2.66% |
| Mahendran Devika | 1.97% |
| K S Ramalingam | 1.46% |
| Urvija Choudhary | 1.44% |
| Madhavi Rubin Chheda | 1.06% |
9,572 shareholders. Pledged: 87.15% of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| LOTUSEYE | ₹236 cr | 1,419.5x | 3.9x | 0.2% | 2.1% | 8.5% | +4.5% | 0.01% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2023-09-18 | Dividend | Dividend - Re 0.50 Per Share |
| 2023-09-18 | Other | Annual General Meeting |
| 2022-09-08 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Sh |
| 2021-09-08 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 2020-11-19 | Other | Annual General Meeting |
| 2019-09-16 | Other | Annual General Meeting |
| 2018-09-14 | Dividend | Annual General Meeting/Dividend Re 0.5 Per Share |
| 2018-09-14 | Dividend | Annual General Meeting/Dividend Re 0.5 Per Share |
| 2017-08-02 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
| 2016-08-23 | Other | Annual General Meeting |
| 2015-09-18 | Other | Annual General Meeting |
| 2014-09-16 | Other | Annual General Meeting |
| 2013-09-17 | Other | Annual General Meeting |
| 2012-09-14 | Other | Annual General Meeting |
| 2011-09-20 | Other | Annual General Meeting |
| 2010-09-08 | Other | Annual General Meeting |
| 2009-09-23 | Other | Annual General Meeting |
| 2008-09-24 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | LOTUSEYE |
| BSE code | 532998 |
| ISIN | INE947I01017 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.